nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AHR—lung cancer	0.334	0.763	CbGaD
Flutamide—CYP1A1—lung cancer	0.104	0.237	CbGaD
Flutamide—CYP1B1—Erlotinib—lung cancer	0.0416	0.112	CbGbCtD
Flutamide—CYP1B1—Paclitaxel—lung cancer	0.0381	0.103	CbGbCtD
Flutamide—CYP1A1—Gefitinib—lung cancer	0.0309	0.0835	CbGbCtD
Flutamide—CYP1B1—Docetaxel—lung cancer	0.0276	0.0744	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—lung cancer	0.0205	0.0555	CbGbCtD
Flutamide—CYP3A5—Gefitinib—lung cancer	0.0185	0.0501	CbGbCtD
Flutamide—CYP1A1—Erlotinib—lung cancer	0.0183	0.0493	CbGbCtD
Flutamide—CYP3A5—Teniposide—lung cancer	0.018	0.0486	CbGbCtD
Flutamide—CYP2C19—Gefitinib—lung cancer	0.015	0.0404	CbGbCtD
Flutamide—CYP2C19—Teniposide—lung cancer	0.0145	0.0392	CbGbCtD
Flutamide—CYP3A5—Crizotinib—lung cancer	0.0114	0.0307	CbGbCtD
Flutamide—CYP3A5—Erlotinib—lung cancer	0.011	0.0296	CbGbCtD
Flutamide—CYP3A5—Paclitaxel—lung cancer	0.01	0.0271	CbGbCtD
Flutamide—CYP3A5—Irinotecan—lung cancer	0.0099	0.0267	CbGbCtD
Flutamide—CYP1A2—Erlotinib—lung cancer	0.00816	0.022	CbGbCtD
Flutamide—CYP3A5—Etoposide—lung cancer	0.00793	0.0214	CbGbCtD
Flutamide—CYP3A4—Topotecan—lung cancer	0.00791	0.0214	CbGbCtD
Flutamide—CYP3A5—Docetaxel—lung cancer	0.00726	0.0196	CbGbCtD
Flutamide—CYP3A4—Gefitinib—lung cancer	0.00723	0.0195	CbGbCtD
Flutamide—CYP3A4—Teniposide—lung cancer	0.00701	0.0189	CbGbCtD
Flutamide—CYP1A2—Etoposide—lung cancer	0.0059	0.0159	CbGbCtD
Flutamide—CYP3A4—Vinorelbine—lung cancer	0.00557	0.015	CbGbCtD
Flutamide—CYP3A4—Crizotinib—lung cancer	0.00443	0.012	CbGbCtD
Flutamide—CYP3A4—Erlotinib—lung cancer	0.00428	0.0115	CbGbCtD
Flutamide—CYP3A4—Paclitaxel—lung cancer	0.00391	0.0106	CbGbCtD
Flutamide—CYP3A4—Irinotecan—lung cancer	0.00386	0.0104	CbGbCtD
Flutamide—CYP3A4—Vinblastine—lung cancer	0.00343	0.00927	CbGbCtD
Flutamide—CYP3A4—Etoposide—lung cancer	0.00309	0.00835	CbGbCtD
Flutamide—CYP3A4—Docetaxel—lung cancer	0.00283	0.00764	CbGbCtD
Flutamide—CYP3A4—Doxorubicin—lung cancer	0.00211	0.0057	CbGbCtD
Flutamide—AHR—bronchus—lung cancer	0.000579	0.0818	CbGeAlD
Flutamide—CYP1B1—mammary gland—lung cancer	0.00055	0.0777	CbGeAlD
Flutamide—AHR—trachea—lung cancer	0.00052	0.0734	CbGeAlD
Flutamide—AHR—cardiac atrium—lung cancer	0.000488	0.069	CbGeAlD
Flutamide—AHR—bone marrow—lung cancer	0.000412	0.0582	CbGeAlD
Flutamide—AHR—lung—lung cancer	0.000374	0.0528	CbGeAlD
Flutamide—CYP1B1—respiratory system—lung cancer	0.000366	0.0518	CbGeAlD
Flutamide—AR—epithelium—lung cancer	0.00029	0.041	CbGeAlD
Flutamide—AR—bronchus—lung cancer	0.000286	0.0403	CbGeAlD
Flutamide—CYP1A2—respiratory system—lung cancer	0.000263	0.0371	CbGeAlD
Flutamide—CYP1A1—respiratory system—lung cancer	0.000259	0.0366	CbGeAlD
Flutamide—AHR—lymph node—lung cancer	0.000255	0.0361	CbGeAlD
Flutamide—CYP3A5—respiratory system—lung cancer	0.000253	0.0358	CbGeAlD
Flutamide—AR—cardiac atrium—lung cancer	0.000241	0.034	CbGeAlD
Flutamide—CYP1A1—epithelium—lung cancer	0.000216	0.0306	CbGeAlD
Flutamide—CYP1A1—bronchus—lung cancer	0.000213	0.0301	CbGeAlD
Flutamide—CYP1B1—lung—lung cancer	0.000195	0.0275	CbGeAlD
Flutamide—CYP1A1—trachea—lung cancer	0.000191	0.027	CbGeAlD
Flutamide—AR—lung—lung cancer	0.000184	0.026	CbGeAlD
Flutamide—CYP1A1—cardiac atrium—lung cancer	0.00018	0.0254	CbGeAlD
Flutamide—CYP1A2—lung—lung cancer	0.000139	0.0197	CbGeAlD
Flutamide—CYP1A1—lung—lung cancer	0.000138	0.0194	CbGeAlD
Flutamide—CYP3A5—lung—lung cancer	0.000134	0.019	CbGeAlD
Flutamide—CYP1B1—lymph node—lung cancer	0.000133	0.0188	CbGeAlD
Flutamide—AR—lymph node—lung cancer	0.000126	0.0178	CbGeAlD
Flutamide—Discomfort—Irinotecan—lung cancer	0.000111	0.00105	CcSEcCtD
Flutamide—Hypertension—Gemcitabine—lung cancer	0.000111	0.00105	CcSEcCtD
Flutamide—Anaemia—Cisplatin—lung cancer	0.00011	0.00104	CcSEcCtD
Flutamide—Asthenia—Topotecan—lung cancer	0.000109	0.00103	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—lung cancer	0.000108	0.00102	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000108	0.00102	CcSEcCtD
Flutamide—Confusional state—Irinotecan—lung cancer	0.000108	0.00102	CcSEcCtD
Flutamide—Asthenia—Erlotinib—lung cancer	0.000108	0.00102	CcSEcCtD
Flutamide—Discomfort—Gemcitabine—lung cancer	0.000108	0.00102	CcSEcCtD
Flutamide—Malaise—Cisplatin—lung cancer	0.000108	0.00102	CcSEcCtD
Flutamide—Pruritus—Topotecan—lung cancer	0.000108	0.00102	CcSEcCtD
Flutamide—Oedema—Irinotecan—lung cancer	0.000107	0.00101	CcSEcCtD
Flutamide—Erythema—Paclitaxel—lung cancer	0.000107	0.00101	CcSEcCtD
Flutamide—Feeling abnormal—Vinorelbine—lung cancer	0.000107	0.00101	CcSEcCtD
Flutamide—Diarrhoea—Vinblastine—lung cancer	0.000107	0.00101	CcSEcCtD
Flutamide—Leukopenia—Cisplatin—lung cancer	0.000107	0.00101	CcSEcCtD
Flutamide—Pruritus—Erlotinib—lung cancer	0.000106	0.00101	CcSEcCtD
Flutamide—Tension—Paclitaxel—lung cancer	0.000105	0.000995	CcSEcCtD
Flutamide—Thrombocytopenia—Irinotecan—lung cancer	0.000105	0.000994	CcSEcCtD
Flutamide—Oedema—Gemcitabine—lung cancer	0.000105	0.000989	CcSEcCtD
Flutamide—Hepatitis—Docetaxel—lung cancer	0.000104	0.000987	CcSEcCtD
Flutamide—Nervousness—Paclitaxel—lung cancer	0.000104	0.000985	CcSEcCtD
Flutamide—Diarrhoea—Topotecan—lung cancer	0.000104	0.000984	CcSEcCtD
Flutamide—Dizziness—Vinblastine—lung cancer	0.000104	0.000979	CcSEcCtD
Flutamide—Diarrhoea—Erlotinib—lung cancer	0.000103	0.000974	CcSEcCtD
Flutamide—Oedema peripheral—Docetaxel—lung cancer	0.000103	0.000973	CcSEcCtD
Flutamide—Thrombocytopenia—Gemcitabine—lung cancer	0.000102	0.000968	CcSEcCtD
Flutamide—Anorexia—Irinotecan—lung cancer	0.000102	0.000967	CcSEcCtD
Flutamide—Skin disorder—Gemcitabine—lung cancer	0.000102	0.00096	CcSEcCtD
Flutamide—Ill-defined disorder—Etoposide—lung cancer	0.000101	0.00096	CcSEcCtD
Flutamide—Anxiety—Cisplatin—lung cancer	0.000101	0.000958	CcSEcCtD
Flutamide—Anaemia—Etoposide—lung cancer	0.000101	0.000956	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000101	0.000955	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—lung cancer	0.000101	0.000952	CcSEcCtD
Flutamide—Dizziness—Topotecan—lung cancer	0.000101	0.000951	CcSEcCtD
Flutamide—Discomfort—Cisplatin—lung cancer	0.0001	0.00095	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—lung cancer	0.0001	0.000948	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—lung cancer	9.98e-05	0.000944	CcSEcCtD
Flutamide—Anorexia—Gemcitabine—lung cancer	9.97e-05	0.000942	CcSEcCtD
Flutamide—Vomiting—Vinblastine—lung cancer	9.96e-05	0.000941	CcSEcCtD
Flutamide—Dizziness—Erlotinib—lung cancer	9.95e-05	0.000941	CcSEcCtD
Flutamide—Ill-defined disorder—Paclitaxel—lung cancer	9.95e-05	0.000941	CcSEcCtD
Flutamide—Anaemia—Paclitaxel—lung cancer	9.91e-05	0.000937	CcSEcCtD
Flutamide—Malaise—Etoposide—lung cancer	9.86e-05	0.000933	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—lung cancer	9.86e-05	0.000932	CcSEcCtD
Flutamide—Headache—Vinblastine—lung cancer	9.81e-05	0.000928	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Methotrexate—lung cancer	9.8e-05	0.000926	CcSEcCtD
Flutamide—Leukopenia—Etoposide—lung cancer	9.79e-05	0.000926	CcSEcCtD
Flutamide—Oedema—Cisplatin—lung cancer	9.74e-05	0.000921	CcSEcCtD
Flutamide—Insomnia—Irinotecan—lung cancer	9.71e-05	0.000918	CcSEcCtD
Flutamide—Vomiting—Topotecan—lung cancer	9.67e-05	0.000915	CcSEcCtD
Flutamide—Malaise—Paclitaxel—lung cancer	9.67e-05	0.000914	CcSEcCtD
Flutamide—Leukopenia—Paclitaxel—lung cancer	9.6e-05	0.000908	CcSEcCtD
Flutamide—Rash—Topotecan—lung cancer	9.59e-05	0.000907	CcSEcCtD
Flutamide—Dermatitis—Topotecan—lung cancer	9.58e-05	0.000906	CcSEcCtD
Flutamide—Vomiting—Erlotinib—lung cancer	9.57e-05	0.000905	CcSEcCtD
Flutamide—Somnolence—Irinotecan—lung cancer	9.54e-05	0.000902	CcSEcCtD
Flutamide—Thrombocytopenia—Cisplatin—lung cancer	9.54e-05	0.000902	CcSEcCtD
Flutamide—Headache—Topotecan—lung cancer	9.53e-05	0.000901	CcSEcCtD
Flutamide—Rash—Erlotinib—lung cancer	9.49e-05	0.000897	CcSEcCtD
Flutamide—Dermatitis—Erlotinib—lung cancer	9.48e-05	0.000896	CcSEcCtD
Flutamide—Skin disorder—Cisplatin—lung cancer	9.46e-05	0.000895	CcSEcCtD
Flutamide—Insomnia—Gemcitabine—lung cancer	9.46e-05	0.000894	CcSEcCtD
Flutamide—Hypertension—Etoposide—lung cancer	9.44e-05	0.000893	CcSEcCtD
Flutamide—Headache—Erlotinib—lung cancer	9.43e-05	0.000892	CcSEcCtD
Flutamide—CYP1A1—lymph node—lung cancer	9.41e-05	0.0133	CbGeAlD
Flutamide—Asthenia—Vinorelbine—lung cancer	9.34e-05	0.000883	CcSEcCtD
Flutamide—Decreased appetite—Irinotecan—lung cancer	9.33e-05	0.000882	CcSEcCtD
Flutamide—Nausea—Vinblastine—lung cancer	9.3e-05	0.000879	CcSEcCtD
Flutamide—Somnolence—Gemcitabine—lung cancer	9.29e-05	0.000879	CcSEcCtD
Flutamide—Anorexia—Cisplatin—lung cancer	9.29e-05	0.000878	CcSEcCtD
Flutamide—Hypertension—Paclitaxel—lung cancer	9.26e-05	0.000876	CcSEcCtD
Flutamide—Fatigue—Irinotecan—lung cancer	9.25e-05	0.000875	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	9.25e-05	0.000874	CcSEcCtD
Flutamide—Pruritus—Vinorelbine—lung cancer	9.21e-05	0.000871	CcSEcCtD
Flutamide—Discomfort—Etoposide—lung cancer	9.2e-05	0.00087	CcSEcCtD
Flutamide—Constipation—Irinotecan—lung cancer	9.18e-05	0.000868	CcSEcCtD
Flutamide—Anxiety—Paclitaxel—lung cancer	9.1e-05	0.00086	CcSEcCtD
Flutamide—Erythema—Docetaxel—lung cancer	9.09e-05	0.00086	CcSEcCtD
Flutamide—Decreased appetite—Gemcitabine—lung cancer	9.09e-05	0.000859	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	9.07e-05	0.000857	CcSEcCtD
Flutamide—Nausea—Topotecan—lung cancer	9.04e-05	0.000854	CcSEcCtD
Flutamide—Discomfort—Paclitaxel—lung cancer	9.02e-05	0.000853	CcSEcCtD
Flutamide—Fatigue—Gemcitabine—lung cancer	9.01e-05	0.000852	CcSEcCtD
Flutamide—Confusional state—Etoposide—lung cancer	9e-05	0.000851	CcSEcCtD
Flutamide—Constipation—Gemcitabine—lung cancer	8.94e-05	0.000845	CcSEcCtD
Flutamide—Nausea—Erlotinib—lung cancer	8.94e-05	0.000845	CcSEcCtD
Flutamide—Diarrhoea—Vinorelbine—lung cancer	8.9e-05	0.000842	CcSEcCtD
Flutamide—Feeling abnormal—Irinotecan—lung cancer	8.84e-05	0.000836	CcSEcCtD
Flutamide—Confusional state—Paclitaxel—lung cancer	8.83e-05	0.000835	CcSEcCtD
Flutamide—Oedema—Paclitaxel—lung cancer	8.75e-05	0.000828	CcSEcCtD
Flutamide—Thrombocytopenia—Etoposide—lung cancer	8.74e-05	0.000826	CcSEcCtD
Flutamide—Skin disorder—Etoposide—lung cancer	8.67e-05	0.00082	CcSEcCtD
Flutamide—Erectile dysfunction—Methotrexate—lung cancer	8.66e-05	0.000819	CcSEcCtD
Flutamide—Feeling abnormal—Gemcitabine—lung cancer	8.61e-05	0.000815	CcSEcCtD
Flutamide—Dizziness—Vinorelbine—lung cancer	8.61e-05	0.000814	CcSEcCtD
Flutamide—Photosensitivity reaction—Methotrexate—lung cancer	8.58e-05	0.000812	CcSEcCtD
Flutamide—Thrombocytopenia—Paclitaxel—lung cancer	8.57e-05	0.00081	CcSEcCtD
Flutamide—Anorexia—Etoposide—lung cancer	8.51e-05	0.000805	CcSEcCtD
Flutamide—Skin disorder—Paclitaxel—lung cancer	8.5e-05	0.000804	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—lung cancer	8.48e-05	0.000802	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—lung cancer	8.48e-05	0.000802	CcSEcCtD
Flutamide—Decreased appetite—Cisplatin—lung cancer	8.47e-05	0.000801	CcSEcCtD
Flutamide—Anaemia—Docetaxel—lung cancer	8.4e-05	0.000794	CcSEcCtD
Flutamide—Drowsiness—Methotrexate—lung cancer	8.38e-05	0.000793	CcSEcCtD
Flutamide—Anorexia—Paclitaxel—lung cancer	8.34e-05	0.000789	CcSEcCtD
Flutamide—Vomiting—Vinorelbine—lung cancer	8.27e-05	0.000782	CcSEcCtD
Flutamide—Rash—Vinorelbine—lung cancer	8.2e-05	0.000776	CcSEcCtD
Flutamide—Dermatitis—Vinorelbine—lung cancer	8.2e-05	0.000775	CcSEcCtD
Flutamide—Headache—Vinorelbine—lung cancer	8.15e-05	0.000771	CcSEcCtD
Flutamide—Leukopenia—Docetaxel—lung cancer	8.14e-05	0.000769	CcSEcCtD
Flutamide—Feeling abnormal—Cisplatin—lung cancer	8.03e-05	0.000759	CcSEcCtD
Flutamide—Haematuria—Methotrexate—lung cancer	7.99e-05	0.000756	CcSEcCtD
Flutamide—Somnolence—Etoposide—lung cancer	7.94e-05	0.00075	CcSEcCtD
Flutamide—Insomnia—Paclitaxel—lung cancer	7.92e-05	0.000749	CcSEcCtD
Flutamide—Hypertension—Docetaxel—lung cancer	7.85e-05	0.000742	CcSEcCtD
Flutamide—Somnolence—Paclitaxel—lung cancer	7.78e-05	0.000736	CcSEcCtD
Flutamide—Decreased appetite—Etoposide—lung cancer	7.76e-05	0.000734	CcSEcCtD
Flutamide—Nausea—Vinorelbine—lung cancer	7.73e-05	0.000731	CcSEcCtD
Flutamide—Asthenia—Irinotecan—lung cancer	7.7e-05	0.000728	CcSEcCtD
Flutamide—Fatigue—Etoposide—lung cancer	7.7e-05	0.000728	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	7.69e-05	0.000727	CcSEcCtD
Flutamide—Constipation—Etoposide—lung cancer	7.63e-05	0.000722	CcSEcCtD
Flutamide—Decreased appetite—Paclitaxel—lung cancer	7.61e-05	0.000719	CcSEcCtD
Flutamide—Fatigue—Paclitaxel—lung cancer	7.55e-05	0.000714	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—lung cancer	7.53e-05	0.000712	CcSEcCtD
Flutamide—Asthenia—Gemcitabine—lung cancer	7.5e-05	0.000709	CcSEcCtD
Flutamide—Constipation—Paclitaxel—lung cancer	7.48e-05	0.000708	CcSEcCtD
Flutamide—Confusional state—Docetaxel—lung cancer	7.48e-05	0.000707	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—lung cancer	7.43e-05	0.000703	CcSEcCtD
Flutamide—Oedema—Docetaxel—lung cancer	7.42e-05	0.000702	CcSEcCtD
Flutamide—Pruritus—Gemcitabine—lung cancer	7.4e-05	0.000699	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—lung cancer	7.36e-05	0.000696	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—lung cancer	7.34e-05	0.000694	CcSEcCtD
Flutamide—Diarrhoea—Irinotecan—lung cancer	7.34e-05	0.000694	CcSEcCtD
Flutamide—Thrombocytopenia—Docetaxel—lung cancer	7.26e-05	0.000687	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—lung cancer	7.26e-05	0.000686	CcSEcCtD
Flutamide—Feeling abnormal—Paclitaxel—lung cancer	7.21e-05	0.000682	CcSEcCtD
Flutamide—Skin disorder—Docetaxel—lung cancer	7.21e-05	0.000681	CcSEcCtD
Flutamide—Diarrhoea—Gemcitabine—lung cancer	7.15e-05	0.000676	CcSEcCtD
Flutamide—Dizziness—Irinotecan—lung cancer	7.1e-05	0.000671	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—lung cancer	7.08e-05	0.000669	CcSEcCtD
Flutamide—Anorexia—Docetaxel—lung cancer	7.07e-05	0.000669	CcSEcCtD
Flutamide—Asthenia—Cisplatin—lung cancer	6.99e-05	0.000661	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—lung cancer	6.92e-05	0.000655	CcSEcCtD
Flutamide—Vomiting—Irinotecan—lung cancer	6.82e-05	0.000645	CcSEcCtD
Flutamide—Rash—Irinotecan—lung cancer	6.77e-05	0.00064	CcSEcCtD
Flutamide—Dermatitis—Irinotecan—lung cancer	6.76e-05	0.000639	CcSEcCtD
Flutamide—Headache—Irinotecan—lung cancer	6.72e-05	0.000636	CcSEcCtD
Flutamide—Insomnia—Docetaxel—lung cancer	6.71e-05	0.000634	CcSEcCtD
Flutamide—Diarrhoea—Cisplatin—lung cancer	6.67e-05	0.00063	CcSEcCtD
Flutamide—Vomiting—Gemcitabine—lung cancer	6.65e-05	0.000629	CcSEcCtD
Flutamide—Somnolence—Docetaxel—lung cancer	6.6e-05	0.000624	CcSEcCtD
Flutamide—Rash—Gemcitabine—lung cancer	6.59e-05	0.000623	CcSEcCtD
Flutamide—Dermatitis—Gemcitabine—lung cancer	6.59e-05	0.000623	CcSEcCtD
Flutamide—Erythema—Methotrexate—lung cancer	6.55e-05	0.00062	CcSEcCtD
Flutamide—Headache—Gemcitabine—lung cancer	6.55e-05	0.000619	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—lung cancer	6.52e-05	0.000616	CcSEcCtD
Flutamide—Decreased appetite—Docetaxel—lung cancer	6.45e-05	0.00061	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—lung cancer	6.42e-05	0.000607	CcSEcCtD
Flutamide—Asthenia—Etoposide—lung cancer	6.4e-05	0.000606	CcSEcCtD
Flutamide—Fatigue—Docetaxel—lung cancer	6.4e-05	0.000605	CcSEcCtD
Flutamide—Nausea—Irinotecan—lung cancer	6.37e-05	0.000603	CcSEcCtD
Flutamide—Constipation—Docetaxel—lung cancer	6.34e-05	0.0006	CcSEcCtD
Flutamide—Pruritus—Etoposide—lung cancer	6.32e-05	0.000597	CcSEcCtD
Flutamide—Asthenia—Paclitaxel—lung cancer	6.28e-05	0.000594	CcSEcCtD
Flutamide—Nausea—Gemcitabine—lung cancer	6.21e-05	0.000587	CcSEcCtD
Flutamide—Vomiting—Cisplatin—lung cancer	6.2e-05	0.000586	CcSEcCtD
Flutamide—Pruritus—Paclitaxel—lung cancer	6.19e-05	0.000586	CcSEcCtD
Flutamide—Rash—Cisplatin—lung cancer	6.14e-05	0.000581	CcSEcCtD
Flutamide—Dermatitis—Cisplatin—lung cancer	6.14e-05	0.00058	CcSEcCtD
Flutamide—Feeling abnormal—Docetaxel—lung cancer	6.11e-05	0.000578	CcSEcCtD
Flutamide—Diarrhoea—Etoposide—lung cancer	6.11e-05	0.000578	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—lung cancer	6.08e-05	0.000575	CcSEcCtD
Flutamide—Anaemia—Methotrexate—lung cancer	6.06e-05	0.000573	CcSEcCtD
Flutamide—Diarrhoea—Paclitaxel—lung cancer	5.99e-05	0.000566	CcSEcCtD
Flutamide—Malaise—Methotrexate—lung cancer	5.91e-05	0.000559	CcSEcCtD
Flutamide—Dizziness—Etoposide—lung cancer	5.9e-05	0.000558	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—lung cancer	5.86e-05	0.000555	CcSEcCtD
Flutamide—Dizziness—Paclitaxel—lung cancer	5.79e-05	0.000547	CcSEcCtD
Flutamide—Nausea—Cisplatin—lung cancer	5.79e-05	0.000547	CcSEcCtD
Flutamide—Vomiting—Etoposide—lung cancer	5.68e-05	0.000537	CcSEcCtD
Flutamide—Erythema—Doxorubicin—lung cancer	5.67e-05	0.000536	CcSEcCtD
Flutamide—Rash—Etoposide—lung cancer	5.63e-05	0.000532	CcSEcCtD
Flutamide—Dermatitis—Etoposide—lung cancer	5.62e-05	0.000532	CcSEcCtD
Flutamide—Headache—Etoposide—lung cancer	5.59e-05	0.000529	CcSEcCtD
Flutamide—Tension—Doxorubicin—lung cancer	5.57e-05	0.000526	CcSEcCtD
Flutamide—Vomiting—Paclitaxel—lung cancer	5.57e-05	0.000526	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.54e-05	0.000524	CcSEcCtD
Flutamide—Rash—Paclitaxel—lung cancer	5.52e-05	0.000522	CcSEcCtD
Flutamide—Dermatitis—Paclitaxel—lung cancer	5.51e-05	0.000521	CcSEcCtD
Flutamide—Discomfort—Methotrexate—lung cancer	5.51e-05	0.000521	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—lung cancer	5.51e-05	0.000521	CcSEcCtD
Flutamide—Headache—Paclitaxel—lung cancer	5.48e-05	0.000518	CcSEcCtD
Flutamide—Confusional state—Methotrexate—lung cancer	5.39e-05	0.00051	CcSEcCtD
Flutamide—Asthenia—Docetaxel—lung cancer	5.32e-05	0.000503	CcSEcCtD
Flutamide—Nausea—Etoposide—lung cancer	5.3e-05	0.000501	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—lung cancer	5.26e-05	0.000498	CcSEcCtD
Flutamide—Pruritus—Docetaxel—lung cancer	5.25e-05	0.000496	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—lung cancer	5.24e-05	0.000496	CcSEcCtD
Flutamide—Thrombocytopenia—Methotrexate—lung cancer	5.24e-05	0.000495	CcSEcCtD
Flutamide—Nausea—Paclitaxel—lung cancer	5.2e-05	0.000492	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—lung cancer	5.19e-05	0.000491	CcSEcCtD
Flutamide—Malaise—Doxorubicin—lung cancer	5.12e-05	0.000484	CcSEcCtD
Flutamide—Anorexia—Methotrexate—lung cancer	5.1e-05	0.000482	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—lung cancer	5.08e-05	0.00048	CcSEcCtD
Flutamide—Diarrhoea—Docetaxel—lung cancer	5.08e-05	0.00048	CcSEcCtD
Flutamide—Dizziness—Docetaxel—lung cancer	4.91e-05	0.000464	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—lung cancer	4.9e-05	0.000463	CcSEcCtD
Flutamide—Insomnia—Methotrexate—lung cancer	4.84e-05	0.000457	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—lung cancer	4.81e-05	0.000455	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.8e-05	0.000454	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—lung cancer	4.77e-05	0.000451	CcSEcCtD
Flutamide—Somnolence—Methotrexate—lung cancer	4.75e-05	0.000449	CcSEcCtD
Flutamide—Vomiting—Docetaxel—lung cancer	4.72e-05	0.000446	CcSEcCtD
Flutamide—Rash—Docetaxel—lung cancer	4.68e-05	0.000442	CcSEcCtD
Flutamide—Dermatitis—Docetaxel—lung cancer	4.67e-05	0.000442	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—lung cancer	4.67e-05	0.000441	CcSEcCtD
Flutamide—Decreased appetite—Methotrexate—lung cancer	4.65e-05	0.00044	CcSEcCtD
Flutamide—Headache—Docetaxel—lung cancer	4.65e-05	0.000439	CcSEcCtD
Flutamide—Oedema—Doxorubicin—lung cancer	4.63e-05	0.000438	CcSEcCtD
Flutamide—Fatigue—Methotrexate—lung cancer	4.61e-05	0.000436	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—lung cancer	4.53e-05	0.000429	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—lung cancer	4.5e-05	0.000425	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—lung cancer	4.41e-05	0.000417	CcSEcCtD
Flutamide—Nausea—Docetaxel—lung cancer	4.41e-05	0.000417	CcSEcCtD
Flutamide—Feeling abnormal—Methotrexate—lung cancer	4.41e-05	0.000417	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—lung cancer	4.19e-05	0.000396	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—lung cancer	4.12e-05	0.000389	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—lung cancer	4.02e-05	0.000381	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—lung cancer	3.99e-05	0.000377	CcSEcCtD
Flutamide—Constipation—Doxorubicin—lung cancer	3.96e-05	0.000374	CcSEcCtD
Flutamide—Asthenia—Methotrexate—lung cancer	3.84e-05	0.000363	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—lung cancer	3.82e-05	0.000361	CcSEcCtD
Flutamide—Pruritus—Methotrexate—lung cancer	3.78e-05	0.000358	CcSEcCtD
Flutamide—Diarrhoea—Methotrexate—lung cancer	3.66e-05	0.000346	CcSEcCtD
Flutamide—Dizziness—Methotrexate—lung cancer	3.54e-05	0.000334	CcSEcCtD
Flutamide—Vomiting—Methotrexate—lung cancer	3.4e-05	0.000321	CcSEcCtD
Flutamide—Rash—Methotrexate—lung cancer	3.37e-05	0.000319	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—lung cancer	3.37e-05	0.000319	CcSEcCtD
Flutamide—Headache—Methotrexate—lung cancer	3.35e-05	0.000317	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—lung cancer	3.32e-05	0.000314	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—lung cancer	3.28e-05	0.00031	CcSEcCtD
Flutamide—Nausea—Methotrexate—lung cancer	3.18e-05	0.0003	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—lung cancer	3.17e-05	0.0003	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—lung cancer	3.06e-05	0.00029	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—lung cancer	2.94e-05	0.000278	CcSEcCtD
Flutamide—Rash—Doxorubicin—lung cancer	2.92e-05	0.000276	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—lung cancer	2.92e-05	0.000276	CcSEcCtD
Flutamide—Headache—Doxorubicin—lung cancer	2.9e-05	0.000274	CcSEcCtD
Flutamide—Nausea—Doxorubicin—lung cancer	2.75e-05	0.00026	CcSEcCtD
Flutamide—CYP1B1—Metabolism—CAT—lung cancer	7.35e-06	9.3e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO2—lung cancer	7.32e-06	9.27e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HPGDS—lung cancer	7.32e-06	9.27e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.31e-06	9.25e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2A7—lung cancer	7.28e-06	9.22e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPP2R1B—lung cancer	7.28e-06	9.21e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOA3—lung cancer	7.25e-06	9.18e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTA1—lung cancer	7.16e-06	9.07e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCB1—lung cancer	7.15e-06	9.05e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.13e-06	9.02e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SDC4—lung cancer	7.13e-06	9.02e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HSD17B10—lung cancer	7.11e-06	9e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—lung cancer	7.1e-06	8.99e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCC3—lung cancer	7.08e-06	8.96e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADCY1—lung cancer	7.06e-06	8.93e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCG2—lung cancer	7.06e-06	8.93e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TYMS—lung cancer	7.02e-06	8.89e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GCLC—lung cancer	7.02e-06	8.89e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2A6—lung cancer	7.02e-06	8.89e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTM1—lung cancer	6.94e-06	8.78e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ENO2—lung cancer	6.92e-06	8.76e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HPGDS—lung cancer	6.92e-06	8.76e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPP2R1B—lung cancer	6.88e-06	8.7e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKR1C1—lung cancer	6.86e-06	8.68e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.78e-06	8.59e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—lung cancer	6.71e-06	8.49e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—UGT1A1—lung cancer	6.66e-06	8.43e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO1—lung cancer	6.66e-06	8.42e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GCLC—lung cancer	6.63e-06	8.4e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP2A6—lung cancer	6.63e-06	8.4e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CKB—lung cancer	6.61e-06	8.36e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.61e-06	8.36e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP1A1—lung cancer	6.58e-06	8.33e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ERCC2—lung cancer	6.53e-06	8.26e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RRM1—lung cancer	6.49e-06	8.21e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA3—lung cancer	6.49e-06	8.21e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNG11—lung cancer	6.42e-06	8.13e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.39e-06	8.09e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ENO1—lung cancer	6.29e-06	7.96e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.27e-06	7.93e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CNDP2—lung cancer	6.21e-06	7.86e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM2—lung cancer	6.21e-06	7.86e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.18e-06	7.83e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALDOA—lung cancer	6.11e-06	7.74e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—B4GALT5—lung cancer	6.1e-06	7.72e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTMR3—lung cancer	6.04e-06	7.65e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2E1—lung cancer	5.97e-06	7.56e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA4—lung cancer	5.94e-06	7.51e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOA3—lung cancer	5.94e-06	7.51e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NQO1—lung cancer	5.9e-06	7.47e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PGAM1—lung cancer	5.89e-06	7.46e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.83e-06	7.38e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.8e-06	7.34e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA2—lung cancer	5.78e-06	7.32e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADCY1—lung cancer	5.77e-06	7.31e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCG2—lung cancer	5.77e-06	7.31e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HPGDS—lung cancer	5.66e-06	7.17e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO2—lung cancer	5.66e-06	7.17e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—APOA1—lung cancer	5.65e-06	7.15e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP2E1—lung cancer	5.64e-06	7.14e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPP2R1B—lung cancer	5.63e-06	7.12e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2A7—lung cancer	5.62e-06	7.11e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTA1—lung cancer	5.58e-06	7.06e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NQO1—lung cancer	5.58e-06	7.06e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.55e-06	7.03e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCC3—lung cancer	5.52e-06	6.98e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SDC4—lung cancer	5.5e-06	6.96e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—lung cancer	5.49e-06	6.95e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.46e-06	6.91e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2A6—lung cancer	5.43e-06	6.87e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GCLC—lung cancer	5.43e-06	6.87e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.41e-06	6.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.41e-06	6.84e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.41e-06	6.84e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKR1C1—lung cancer	5.34e-06	6.76e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—STK11—lung cancer	5.32e-06	6.73e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—UGT1A1—lung cancer	5.19e-06	6.57e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—lung cancer	5.15e-06	6.52e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO1—lung cancer	5.15e-06	6.51e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.13e-06	6.49e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.06e-06	6.41e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—STK11—lung cancer	5.03e-06	6.36e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RRM1—lung cancer	5.01e-06	6.34e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA3—lung cancer	5.01e-06	6.34e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNG11—lung cancer	5e-06	6.33e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.98e-06	6.3e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—lung cancer	4.92e-06	6.23e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—POMC—lung cancer	4.91e-06	6.21e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CAT—lung cancer	4.79e-06	6.06e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CREBBP—lung cancer	4.78e-06	6.05e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALDOA—lung cancer	4.76e-06	6.03e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.72e-06	5.97e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—B4GALT5—lung cancer	4.71e-06	5.96e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—lung cancer	4.66e-06	5.9e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—lung cancer	4.65e-06	5.89e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA3—lung cancer	4.62e-06	5.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2E1—lung cancer	4.62e-06	5.84e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA4—lung cancer	4.58e-06	5.8e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMS—lung cancer	4.58e-06	5.79e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NQO1—lung cancer	4.56e-06	5.78e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.54e-06	5.75e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—lung cancer	4.53e-06	5.73e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CAT—lung cancer	4.53e-06	5.73e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAPK3—lung cancer	4.53e-06	5.73e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—lung cancer	4.52e-06	5.73e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.5e-06	5.7e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCG2—lung cancer	4.5e-06	5.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADCY1—lung cancer	4.5e-06	5.69e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—lung cancer	4.47e-06	5.66e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.47e-06	5.66e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA2—lung cancer	4.46e-06	5.65e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.43e-06	5.6e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO2—lung cancer	4.41e-06	5.58e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HPGDS—lung cancer	4.41e-06	5.58e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—lung cancer	4.4e-06	5.57e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—lung cancer	4.4e-06	5.57e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.38e-06	5.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.33e-06	5.47e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMS—lung cancer	4.32e-06	5.47e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA1—lung cancer	4.31e-06	5.45e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1A1—lung cancer	4.29e-06	5.43e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—lung cancer	4.28e-06	5.42e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—lung cancer	4.27e-06	5.41e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCC3—lung cancer	4.26e-06	5.39e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ERCC2—lung cancer	4.25e-06	5.38e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GCLC—lung cancer	4.23e-06	5.35e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2A6—lung cancer	4.23e-06	5.35e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.21e-06	5.33e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKR1C1—lung cancer	4.12e-06	5.22e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—STK11—lung cancer	4.11e-06	5.21e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ERCC2—lung cancer	4.02e-06	5.09e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO1—lung cancer	4.01e-06	5.07e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UGT1A1—lung cancer	4e-06	5.07e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.99e-06	5.06e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—lung cancer	3.95e-06	5e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.94e-06	4.99e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—lung cancer	3.91e-06	4.95e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.86e-06	4.89e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNG11—lung cancer	3.86e-06	4.89e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—lung cancer	3.81e-06	4.82e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CAT—lung cancer	3.7e-06	4.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.68e-06	4.66e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—APOA1—lung cancer	3.68e-06	4.66e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALDOA—lung cancer	3.68e-06	4.65e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—lung cancer	3.6e-06	4.56e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2E1—lung cancer	3.6e-06	4.55e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA3—lung cancer	3.57e-06	4.52e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NQO1—lung cancer	3.56e-06	4.5e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMS—lung cancer	3.54e-06	4.48e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—lung cancer	3.5e-06	4.43e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.48e-06	4.41e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—APOA1—lung cancer	3.48e-06	4.4e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCG2—lung cancer	3.47e-06	4.39e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADCY1—lung cancer	3.47e-06	4.39e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.45e-06	4.37e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—lung cancer	3.41e-06	4.32e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO2—lung cancer	3.4e-06	4.31e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HPGDS—lung cancer	3.4e-06	4.31e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.38e-06	4.28e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—lung cancer	3.36e-06	4.25e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.33e-06	4.21e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1A1—lung cancer	3.32e-06	4.2e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—lung cancer	3.3e-06	4.18e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ERCC2—lung cancer	3.29e-06	4.16e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2A6—lung cancer	3.26e-06	4.13e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GCLC—lung cancer	3.26e-06	4.13e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—lung cancer	3.25e-06	4.12e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—STK11—lung cancer	3.21e-06	4.06e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—POMC—lung cancer	3.2e-06	4.05e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—lung cancer	3.17e-06	4.02e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CREBBP—lung cancer	3.11e-06	3.94e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO1—lung cancer	3.09e-06	3.92e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—lung cancer	3.05e-06	3.86e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—POMC—lung cancer	3.02e-06	3.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.01e-06	3.81e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—lung cancer	2.97e-06	3.75e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—lung cancer	2.95e-06	3.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CREBBP—lung cancer	2.94e-06	3.72e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—lung cancer	2.92e-06	3.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CAT—lung cancer	2.89e-06	3.65e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.87e-06	3.63e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—APOA1—lung cancer	2.84e-06	3.6e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—lung cancer	2.81e-06	3.55e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—lung cancer	2.79e-06	3.53e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2E1—lung cancer	2.78e-06	3.51e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMS—lung cancer	2.76e-06	3.49e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—lung cancer	2.75e-06	3.49e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NQO1—lung cancer	2.74e-06	3.47e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—lung cancer	2.73e-06	3.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.72e-06	3.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—lung cancer	2.6e-06	3.29e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1A1—lung cancer	2.58e-06	3.27e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—lung cancer	2.57e-06	3.26e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ERCC2—lung cancer	2.56e-06	3.24e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—lung cancer	2.55e-06	3.23e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—STK11—lung cancer	2.47e-06	3.13e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—POMC—lung cancer	2.47e-06	3.13e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—lung cancer	2.43e-06	3.08e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—lung cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CREBBP—lung cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—lung cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—lung cancer	2.29e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—lung cancer	2.28e-06	2.89e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—lung cancer	2.25e-06	2.85e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CAT—lung cancer	2.23e-06	2.82e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—lung cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—APOA1—lung cancer	2.22e-06	2.81e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—lung cancer	2.17e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMS—lung cancer	2.13e-06	2.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.12e-06	2.69e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—lung cancer	2.12e-06	2.68e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—lung cancer	2.1e-06	2.66e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—lung cancer	2.1e-06	2.66e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—lung cancer	2.02e-06	2.56e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—lung cancer	2e-06	2.54e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1A1—lung cancer	1.99e-06	2.52e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—lung cancer	1.99e-06	2.52e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ERCC2—lung cancer	1.98e-06	2.5e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—lung cancer	1.97e-06	2.5e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—lung cancer	1.97e-06	2.49e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—POMC—lung cancer	1.93e-06	2.44e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CREBBP—lung cancer	1.88e-06	2.37e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—lung cancer	1.78e-06	2.25e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—lung cancer	1.76e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—lung cancer	1.72e-06	2.18e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—APOA1—lung cancer	1.71e-06	2.17e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—lung cancer	1.64e-06	2.08e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—lung cancer	1.57e-06	1.99e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—lung cancer	1.56e-06	1.98e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—lung cancer	1.55e-06	1.96e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—lung cancer	1.54e-06	1.94e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—POMC—lung cancer	1.49e-06	1.88e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—lung cancer	1.48e-06	1.88e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CREBBP—lung cancer	1.45e-06	1.83e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—lung cancer	1.37e-06	1.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—lung cancer	1.36e-06	1.72e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—lung cancer	1.34e-06	1.7e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—lung cancer	1.28e-06	1.62e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—lung cancer	1.28e-06	1.62e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—lung cancer	1.21e-06	1.54e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—lung cancer	1.21e-06	1.53e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—lung cancer	1.2e-06	1.51e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—lung cancer	1.19e-06	1.5e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—lung cancer	1.03e-06	1.31e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—lung cancer	9.91e-07	1.25e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—lung cancer	9.86e-07	1.25e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—lung cancer	9.45e-07	1.2e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—lung cancer	7.72e-07	9.77e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—lung cancer	7.3e-07	9.23e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—lung cancer	5.96e-07	7.54e-06	CbGpPWpGaD
